| Announce Date | 01/15/2026 |
| EPS Normalized Actual | $2.68 (Beat by $0.25) |
| EPS GAAP Actual | $2.68 (Beat by $0.25) |
| Revenue Actual | $29.989B |
| Revenue Surprise | Beat by $29989M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 13.6879 | 13.32 | 13.01 | 14.12076 | 11 |
| Dec 2028 | 10.67839 | 17.07 | 10.09883 | 11.41254 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.71 | 2.71 | 29.989B | 46.29% | 29989M |
| FQ3 2025 (Sep 2025) | 2.83 | 2.83 | 31.189B | 50.93% | 31189M |
| FQ2 2025 (Jun 2025) | 2.13 | 2.13 | 29.35B | 48.83% | 29350M |
| FQ1 2025 (Mar 2025) | 2.62 | 2.62 | 29.134B | 9.83% | 29134M |
| FQ4 2024 (Dec 2024) | 2.25 | 2.25 | 16.108B | 25.31% | 16108M |
| FQ3 2024 (Sep 2024) | 1.91 | 1.91 | 15.304B | 18.86% | 15304M |
| FQ2 2024 (Jun 2024) | 1.93 | 1.93 | 15.019B | 16.23% | 15019M |
| FQ1 2024 (Mar 2024) | 2.13 | 2.13 | 26.27B | 48.09% | 26270M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 3.7478 | -- | 3.617 | 3.87535 | 2 |
| FQ3 2029 (Sep 2029) | 3.8563 | -- | 3.72171 | 3.98754 | 2 |
| FQ2 2029 (Jun 2029) | 3.4296 | -- | 3.30991 | 3.54632 | 2 |
| FQ1 2029 (Mar 2029) | 3.7947 | -- | 3.66226 | 3.92385 | 3 |
| FQ4 2028 (Dec 2028) | 3.3902 | -- | 3.27188 | 3.50558 | 4 |
| FQ3 2028 (Sep 2028) | 3.5005 | -- | 3.37833 | 3.61963 | 5 |
| FQ2 2028 (Jun 2028) | 3.0989 | -- | 2.99075 | 3.20437 | 6 |
| FQ1 2028 (Mar 2028) | 3.4041 | -- | 3.22356 | 3.59351 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 23.9B | -- | 23.26B | 24.53B | 2 |
| FQ3 2029 (Sep 2029) | 23.85B | -- | 23.21B | 24.48B | 2 |
| FQ2 2029 (Jun 2029) | 22.44B | -- | 21.83B | 23.02B | 2 |
| FQ1 2029 (Mar 2029) | 23.32B | -- | 22.7B | 23.93B | 2 |
| FQ4 2028 (Dec 2028) | 22.29B | -- | 21.7B | 22.88B | 1 |
| FQ3 2028 (Sep 2028) | 22.28B | -- | 21.68B | 22.86B | 1 |
| FQ2 2028 (Jun 2028) | 20.95B | -- | 20.39B | 21.5B | 1 |
| FQ1 2028 (Mar 2028) | 21.52B | -- | 20.64B | 22.44B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.71 | 2.71 | 100% | |
| FQ3 2025 (Sep 2025) | 2.83 | 2.83 | 100% | |
| FQ2 2025 (Jun 2025) | 2.13 | 2.13 | 100% | |
| FQ1 2025 (Mar 2025) | 2.62 | 2.62 | 100% | |
| FQ4 2024 (Dec 2024) | 2.25 | 2.25 | 100% | |
| FQ3 2024 (Sep 2024) | 1.91 | 1.91 | 100% | |
| FQ2 2024 (Jun 2024) | 1.93 | 1.93 | 100% | |
| FQ1 2024 (Mar 2024) | 2.13 | 2.13 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $29.99B | $29989M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $31.19B | $31189M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $29.35B | $29350M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $29.13B | $29134M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $16.11B | $16108M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $15.3B | $15304M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $15.02B | $15019M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $26.27B | $26270M | 100% |